$100 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 7.03% on an annualized basis producing an average annual return of 15.0%. Currently, Gilead Sciences has a market capitalization of $78.63 billion.

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 7.03% on an annualized basis producing an average annual return of 15.0%. Currently, Gilead Sciences has a market capitalization of $78.63 billion.

Buying $100 In GILD: If an investor had bought $100 of GILD stock 20 years ago, it would be worth $1,578.97 today based on a price of $62.69 for GILD at the time of writing.

Gilead Sciences’s Performance Over Last 20 Years

comp_fig

Finally — what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

VerifyMe Updates 2024 Revenue Growth Rate To Be Mid-Single Digit, As Opposed To Double Digit Growth; Expect The Gross Margin Percentage For 2024 Will Be Reduced, But We Still Anticipate The 2024 Gross Margin Percentage, Will Still Exceed The 2023 Gross…

VerifyMe has been notified by its large global carrier customer that it will end subcontracting VerifyMe's Premium logistics service for one of its customers in June 2024.  Discontinuing this contract is not due to

VRME